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Abstract 
 
The prevalence and costs of the obesity epidemic and obesity-related conditions, including 
diabetes mellitus, is consistently increasing worldwide. Bariatric medicine is attempting to 
address this with weight loss and exercise programmes, and with increasing frequency, 
various forms of bariatric surgery. There has been considerable success reported after 
bariatric surgery but not without complications (Billakanty et al, 2008;  Loh et al, 2013; 
Rubinshtein et al, 2001). We describe 14 patients with orthostatic intolerance (OI) post 
bariatric surgery. We report on OI (postural dizziness, palpitations and fainting), the results of 
cardiovascular autonomic testing and the associated and/or causative findings as well as 
reviewing the literature to consider the possible mechanisms.  
 
We propose that the incidence of OI post-bariatric surgery is higher than considered, that 
certain cohorts may be more susceptible to complications, and that further research is needed 
to identify the prevalence and, ideally anticipate occurrence. With the increasing prevalence 
of obesity and required clinical interventions, further understanding of the pathophysiological 
processes causing autonomic dysfunction after bariatric interventions will aid management, 
which may differ in those with an underlying disposition to autonomic involvement, such as 
diabetics, in whom such procedures are increasingly used. 
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Introduction 
 
Obesity is the fifth leading risk for death worldwide and is a predisposing factor for common 
related disorders, such as diabetes, hypertension, stroke, cancer and osteoarthritis (Wang et 
al, 2011). The healthcare footprint of these obesity related diseases indicate that the lifetime 
medical cost of treating an obese individual is 30% more than that of an individual of normal 
weight. It is estimated that obesity or obesity-related treatment accounts for up to 2.8% of a 
country’s total healthcare expenditure (Withrow et al, 2011).  
 
Obesity has reached epidemic proportions in many nations. In England, 61.3% of the adult 
population is overweight (Dept of health, UK., 2013). The World Health Organisation 
(WHO) provides evidence that obesity worldwide has more than doubled since 1980 (WHO, 
Obesity & overweight, 2013), with the United States of America (USA) and the United 
Kingdom (UK), amongst countries with the largest number of current and projected 
overweight and obese individuals (OECD, Key facts , 2010). 
 
 
Figure 1: Past and projected overweight rates  
 
 
Image from OECD site (Key facts, 2010) 
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Bariatric medicine aims to treat obesity by utilising various approaches, such as specific 
weight loss or calorie controlled diets with or without exercise programmes, weight loss 
drugs (for example, Orlistat), and government drives, such as Britain’s ‘Change for 
Life’campaign and the ‘5 A Day Plan’ (Dept of health, UK, 2013). Many bariatric patients 
have tried non-surgical weight loss programmes prior to considering surgery often with 
unsatisfactory results. Research has shown that dietary therapy can be effective, but not for 
sustained weight loss (Buchwald et al, 2004;  Khwaja et al, 2010), as is also the case for 
pharmaceutical weight loss measures.  
 
Bariatric surgery is considered to be one of the most effective methods to treat obesity, 
particularly morbid obesity. Its use in the treatment of Type 2 diabetes has been proposed, as 
it may be more cost effective than other treatments (Keidar, 2011).There are a number of 
procedures that can be used to adapt the gastrointestinal tract to reduce its volume and/or 
absorptive capacity (Khwaja et al, 2010). The procedure chosen for each surgery is patient 
specific with consideration of age, body-mass index (BMI), co-morbidities and previous 
medical history, amongst other aspects. The benefit of these procedures has been well-
documented and include the reduction of diabetic drugs (Schauer et al, 2012) and even 
improvement of autonomic function (Maser et al, 2007). After bariatric surgery patients are 
more productive, take less sick-leave, and utilise fewer healthcare resources. The long-term 
savings of bariatric surgery are estimated to offset the initial costs of the procedure in 2 to 4 
years (Cremieux et al, 2008). These outcomes are beneficial to the patients’ quality of life 
(QoL) (Sjostrom et al, 2007), as well as to the health service. 
 
Documented side-effects, generally surgical in nature, present fairly soon post-operatively 
and are treated rapidly (Khwaja et al, 2010). As bariatric surgery gains popularity in the 
treatment of obesity, complications continue to emerge. We report on a series of such patients 
studied in our units who were referred because of orthostatic intolerance (OI) that may have 
had an autonomic aetiology. 
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Subjects and Methods 
 
Patients: 
We evaluated the records of 14 patients referred over a 5 year period for exclusion of an 
underlying autonomic condition causing or contributing to OI after bariatric surgery (see 
Table 1). These symptoms included dizziness, palpitations and fainting (syncope) when 
upright. Some had additional symptoms affecting other systems, including gastrointestinal 
(GI) disturbances such as abdominal bloating, abdominal pain and diarrhoea. 
 
Table 1: Presenting symptoms 
 
Age 
Time to 
onset 
Presenting Symptoms 
Dizziness Palpitations 
Gastric 
symptoms 
Faint/Falls Sweating 
23 Unknown + - + - - 
25 ~5mths + + + - + 
31 Unknown - - + - - 
36 12 mths - - - + - 
41 36 mths - - + - - 
43 Post op + + + + + 
44 12 mths - - - + - 
45 Post op + - + + - 
45 Post op + - - + - 
46 Unknown - - - - + 
47 Unknown + + + - + 
49 9 mths - - + - + 
52 Post op - + + - - 
61 6 mths + - - + - 
 
 
There were 12 females and 2 males, aged 23-61 (mean age: 42 ±9.9yrs). At initial clinical 
evaluation, some patients had pre-existing medical conditions that could be associated with 
impairment of the autonomic nervous system such as diabetes (see Table 2).  57.1% (8) 
patients had features of joint hypermobility/laxity (JHS), 62.5% (5) of these with a confirmed 
diagnosis of Ehlers-Danlos III (EDS III) (see Table 2). There is a strong association, recently 
recognised, between JHS/EDS III and the postural tachycardia syndrome (PoTS) (Mathias et 
al, 2012). 
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Table 2: Details of procedure, weight loss and allied features 
 
  Age Procedure 
Weight Loss 
(kg) 
Features of JHS/ 
EDS III 
Relevant history 
23 Unknown 47.6 EDS III Hypothyroidism 
25 Roux-en-Y 40 EDS III 
PCOS, Chronic Pain 
Syndrome 
31 Roux-en-Y Unknown Hypermobility Gastroparesis 
36 Roux-en-Y 50 JHS Unknown 
41 LGB 30 JHS CFS 
43 Roux-en-Y 65 EDS III Hypertension 
44 Gastric Band Unknown Unknown Unknown 
45 Roux-en-Y 25.4 Unknown 
Chronic Pain, 
Dumping syndrome, 
Small fibre neuropathy 
45 LSG ~27 Unknown 
Previously 
hypertensive, Diabetic 
46 Roux-en-Y Unknown Unknown 
Rheumatoid arthritis, 
PE 
47 Roux-en-Y 57.2 EDS III CFS 
49 Roux-en-Y ~42.2 Unknown 
Ischaemic heart 
disease, Eating 
disorder 
52 Unknown 25.4 EDS III CFS 
61 LSG ~40 Unknown Unknown 
 
Note:   LSG – Laparoscopy Sleeve Gastrectomy; LGB – Laparoscopy Gastric Band; 
CFS – Chronic Fatigue Syndrome; PE – Pulmonary Embolism; PCOS – Polycystic Ovarian Syndrome 
 
Autonomic investigations were conducted to assess cardiovascular function to exclude 
possible autonomic disease or dysfunction. All tests were performed using protocols 
established in our centres (Mathias et al, 2013). 
 
 Autonomic Function Screening Testing, included head up tilt to 600 and  
cardiovascular autonomic responses to various pressor (e.g. isometric exercise, 
cutaneous cold & mental arithmetic) and respiratory stimuli (e.g. respiratory sinus 
arrhythmia, Valsalva manoeuvre & hyperventilation) designed to assess the 
sympathetic and parasympathetic function. 
 Blood for plasma catecholamines (noradrenaline, adrenaline and dopamine) levels 
were taken while supine and after 10 minutes of tilt or after 5 minutes of standing. 
 Prolonged head up tilting was performed if needed. 
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 Food challenge (liquid meal challenge) (Mathias et al, 2013) was used to identify 
abnormal BP and/or HR changes in response to ingestion of food; and to HUT pre 
and 45 minutes post ingestion of food. 
 24 hour ambulatory BP and HR monitoring using the Autonomic Protocol included 
the responses in different positions to evaluate the effects of posture, exercise and 
food stimuli encountered in daily life (Stuebner et al, 2013). 
 An aAtropine test (Mathias et al, 2013) was performed only in patients who had 
autonomic mediated syncope (AMS), with both a vasodepressor and cardio-inhibitory 
component, to separate the two components. 
 
Results 
 
Autonomic Function Testing 
These tests were performed on all 14 patients. Responses to pressor tests (see methods 
section) were present in all. None of the results indicated cardiovascular autonomic failure. A 
syncopal event was provoked in 7.1% (1) patients during AFT with a HR fall of <40b/m 
necessitating an Atropine test (see below). 35.7 % (5) of the patients had a HR increase with 
orthostasis meeting the criteria for the PoTS. 50% (7) had low levels of BP (<110mmHg) 
during this test. 
 
Plasma Catecholamines 
42.9 %( 6) patients had blood samples taken whilst supine and during orthostasis. The plasma 
catecholamine levels were all within the normal range of our laboratory (normal range for 
noradrenaline: 200-500 pg/ml; adrenaline: 20-150 pg/ml; dopamine: 10-80 pg/ml). 
 
Prolonged Tilt Test 
This test was performed on 50% (7) patients when the shorter period of tilt did not result in 
cardiovascular autonomic changes. An excessive HR response of >30b/m with symptoms 
was observed in 42.9 %( 2) patients during head up tilt, again meeting the diagnostic criteria 
for the PoTS (17, 21). 14.3 %( 1) patients experienced a syncopal episode, with the lowest 
HR recorded at <40b/m requiring an Aatropine test (see below).  
 
Meal Test 
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57.1% (8) patients underwent liquid meal challenge as some were referred because of post-
prandial symptoms of nausea, diarrhoea, bloating, abdominal pain and two referrals 
specifically queried the dumping syndrome. In 37.5 %( 3) patients there were HR rises of 
>30b/m during post-meal tilt associated with symptoms (see Table 3), meeting the diagnostic 
criteria for PoTS (17).  
 
24 hour Ambulatory BP & HR monitoring with Autonomic Protocol 
Low levels of daytime BP (90 -110 mm Hg of systolic BP) were present in 23.1% (3) 
patients. One patient did not wish to complete this test. The nocturnal circadian fall in BP was 
present 46.2% (6) of patients; a modest fall was noted in 23.1% (3); the fall was absent in 
7.7% (1) (this patient did not sleep well during monitoring); and was reversed in 15.4% (2), 
(both having not slept well). A high daytime average HR in 23.1% (3) of patients was noted 
(87-94 b/m). Evidence for PoTS during recording was observed in 15.4% (2) of patients. 
 
Atropine Test 
The antimuscarinic agent, aAtropine, was used to increase HR during HUT to determine if a 
provoked syncopal event was predominantly vasodepressor or cardio inhibitory in nature. 
The test was performed on 2 patients who experienced syncopal episodes on tilt, during 
which HR fell lower than 40b/m in addition to a fall in BP. In each patient the syncopal 
episodes were characteristic of the vasodepressor form of autonomic mediated syncope 
(AMS), and there was therefore no case for consideration of a cardiac demand pacemaker. 
 
 
Table 3: Key cardiovascular autonomic features on testing 
 
Age 
 
Data obtained from tests 
Low BP 
Pre Syncope symptoms 
/Syncope 
PoTS 
23 + - + 
25 - - - 
31 - + - 
36 + - + 
41 + + - 
43 - - + 
44 + + - 
45 - - - 
45 + + - 
46 - - - 
47 + - + 
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49 + - - 
52 + + + 
61 - + - 
 
 
Discussion: 
In this study, we have retrospectively reviewed the causes and autonomic investigations for 
OI in patients referred because of apparent OI that occurred post-bariatric surgery, and to 
exclude an autonomic disorder. The symptom onset varied from immediately post-operative 
to 3 years post-surgery. 
 
Detailed autonomic function testing for causes of intermittent or irreversible autonomic 
failure (AF) indicated that there was no evidence for impairment of the sympathetic 
vasoconstrictor function or cardiac parasympathetic function, thus excluding AF. 57.1% (6) 
of the cohort had low supine levels of BP (systolic readings of<110mmHg) during testing. 
42.9% (6) of patients reported pre-syncopal symptoms and 14.3% (2) patients experienced 
syncopal episodes during HUT, pHUT and/or standing. 35.7% (5) had an inappropriate HR 
response to orthostasis with increases of up to 59b/m. In these patients, the criteria for PoTS 
was fulfilled, with a rise in HR of 30b/m or more, or a HR of > 120b/m with orthostasis either 
during a 10 minute tilt or standing (Mathias et al, 2012; Freeman et al, 2011). Each of these 
patients also had features of the Joint Hypermobility Syndrome (JHS) with a later confirmed 
diagnosis of Ehlers-Danlos Syndrome hypermobility type III (EDS III) which is strongly 
associated with PoTS (Mathias et al, 2012). All of these patients also underwent the Roux-en-
Y gastric bypass surgery.  
 
We have reviewed previous publications, mainly case reports, on OI and Autonomic 
dysfunction after bariatric surgery, and these are referred to below. 
 
In 2001 Rubinshtein et al  reported a single patient with severe orthostatic hypotension (OH) 
after substantial weight loss post-bariatric surgery. OH was only resolved after weight gain. 
Autonomic testing was not performed and whether OH was a transient autonomic 
disturbance, spontaneously resolved or was rectified by medication remains unclear. An 
explanation is that as weight increased so did BP (Billakanty et al,2008; Rubinshtein et al, 
2001). The reverse, BP decrease with weight loss, is consistent with observations in 
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hypertensive patients treated with antihypertensive agents and also in hypertensive patients 
who underwent bariatric surgery and lost weight (Schauer et al, 2012;  Maser et al, 2007).  
 
A series similar in number to ours was reported in 2008 by Billakanty et al  on OI after 
bariatric surgery. All patients underwent tilt table testing although without autonomic 
investigation. Of the 15 patients reported 53% (8) had a neurocardiogenic response, 20% (3) 
had a dysautonomic response and 20% (3) had tachycardia and a PoTS response. In their 
study, Isoproterenol was infused, a drug known to induce syncope even in those without a 
history of syncope, and whether this contributed to tachycardia, independently of the 
underlying pathophysiological processes remains unclear. Of note is that prior to tilt testing, 3 
patients had pacemakers fitted (with no benefit), 12 had been evaluated by a neurologist 
(without autonomic testing), 9 by an endocrinologist, and 5 by an ENT specialist, 
emphasising the problems when an autonomic cause is initially not considered. This study 
concluded that further investigation was necessary to determine the true incidence of OI 
following bariatric surgery, to identify patients at greater risk for developing OI following 
this surgery and to improve understanding of the underlying pathophysiology. 
 
Recently, Loh et al  described a patient with persistent bradycardia post-surgery (~40b/m) 
who had a neurocardiogenic form of syncope on tilt table testing. The description indicates 
that at the beginning of tilt, the HR rose to 120-130b/m, despite a resting HR of 40b/m and 
consistent with a diagnosis of PoTS. Consequently a pacemaker was fitted with apparent 
resolution of symptoms. The length of follow up with this patient was not described. As in 
previous studies, autonomic function testing was not carried out. 
 
Due to the strong association between JHS/EDS III and PoTS (Mathias et al, 2012; Fikree et 
al,2013), it should be important to consider this electively in anticipation of possible side-
effects of surgery. JHS/EDS III can be clinically determined readily (Fikree et al, 2013) and 
is of especially importance in those undergoing surgery as this connective tissue disorder is 
associated with GI dysfunction (Fikree et al, 2013) and also influences response to 
anaesthesia, to analgesics post-operatively and to recovery/wound healing time (Fikree et al, 
2013). 
 
This retrospective study has limitations as referrals were made by healthcare practitioners 
who were aware of our autonomic interests and considered autonomic dysfunction as a 
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possibility. There are likely, as from the literature analysed, to be many more patients with OI 
in whom an autonomic aetiology is not considered. The size of the cohort is small, drug 
regimens and procedures performed varied between patients and also the time of evaluation 
from surgery. It would have been ideal to have tested autonomic function pre surgery.   
 
We have speculated on some of the mechanisms, including gut peptides that may contribute 
to OI after bariatric surgery.  
 
Weight loss itself may be the factor in some, especially if substantial. The largest proportion 
of weight appears to be lost 6 to 24 months post-surgery (Brolin et al, 1994; Behbehrani et al, 
2014).The physiological changes from reducing BMI from severely obese to normal may be 
comparable to those with anorexia, in whom autonomic impairment, affecting sympathetic 
function, has been well documented (Cong et al, 2004). Repeated hypoglycaemia (Cryer, 
2005), which may occur post-bariatric surgery, may contribute. Plasma catecholamine levels, 
a marker of sympathetic activation, are lower in anorexic patients than controls (Cong et al, 
2004); there have been no similar studies post-bariatric surgery. Grassi et al  (2014) has 
reported that elevated sympathetic nerve activity (SNA) in the obese is markedly reduced 
with weight loss post-bariatric surgery. 
 
Gut peptides have a role in cardiovascular autonomic regulation, as exemplified in studies in 
various autonomic disorders (Bishop et al, 2013). Levels of gut peptides are altered post-
bariatric surgery, generally speeding up the feeling of satiety due to increases in peptide YY 
(PYY) (Vincent et al, 2008; Da Silva et al, 2012), PYY binds to neuropeptide Y (NPY), 
which is responsible for increasing food intake, thereby negating its function. This raises the 
question of whether changes in gut peptides and/or hormones impact other circulating 
centrally mediated hormones have the dual purpose of aiding gut function and control of BP 
and HR levels e.g., NPY, acetylcholine, and noradrenaline (Bishop et al, 2013).  
 
There is increasing evidence that leptin not only triggers satiety but may be involved in 
autonomic regulation (Paolisso et al, 2000). Leptin may have vasodilator effects (Lembo et 
al, 2000). As the stomach size is reduced in these patients, the release of leptin to signal 
satiety could be triggered earlier. Combined with the likely need for frequent smaller meals, 
there could be a more frequent release of leptin which as a vasodilator, could explain the 
lowering in BP and/or OI. The role of leptin in autonomic regulation, however, remains 
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controversial. Some report vasoconstrictor effects (Geloneze et al, 2001). Leptin levels 
decrease as the BMI decreases post-surgery (Ram et al, 2005, Takimoto et al, 2014) also 
noted in anorexic patients (Machleidt et al, 2013). Leptin infusion increases vasoconstrictor 
SNA measured by sympathetic microneurography (Cammisotto et al, 2007), and the decrease 
in leptin levels with surgical weight loss (Servalle et al, 2014) may contribute through a 
decrease in sympathetic activity. Leptin may also be further reduced by the loss of leptin-
releasing white adipose tissue (Nayaga et al, 2001) post-surgery, which could worsen OI. The 
exact function of leptin requires further investigation as does another vasodilator peptide, 
Ghrelin (Lembo et al, 2000). 
 
Infusion of ghrelin decreases BP without compensatory increases in HR, suggesting effects 
independent of vasodilatation alone (Nayaga et al, 2001). It is relevant that 54% of our case 
series were found to have features of JHS/EDS III (57.1% with a confirmed diagnosis of EDS 
III), compared to the prevalence of 20% in the general population (Mulvey et al, 2013), 
potentially predisposing them to be sensitised to the apparent depressor effects of ghrelin. 
Rodent studies have provided evidence of ghrelin’s neuroactive properties, particularly on 
autonomic centres (e.g., nucleus of the solitary tract, dorsomotor nucleus of the vagus), 
potentially influencing BP regulation and parasympathetic cardiac tone respectably, both 
primary symptoms of OI. Ghrelin levels increase and leptin levels decrease during food 
deprivation (Saladin et al, 1995), which may be comparable to the marked reduction in 
calorific intake post-surgery. With potentially increased circulatory levels of ghrelin post-
bariatric surgery, it could be argued that ghrelin’s peripheral vasodilatory affects and central 
anti-sympathetic affects may have contributed to the OI. 
 
A recent study (Lee et al, 2015) looking at the prevalence of hypoglycaemic symptoms in 
patients after bariatric surgery found that autonomic symptoms were more prevalent than 
neuroglycopenic symptoms. However, some symptoms of hypoglycaemia overlap autonomic 
symptoms and hypoglycaemia may, in fact, bring on autonomic symptoms. It is unclear from 
this questionnaire study if patients reporting these symptoms had clinically confirmed 
hypoglycaemia and/or had experienced hypoglycaemic and autonomic symptoms 
independent of each other. They also concluded though that the prevalence of these 
symptoms are under-reported. 
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There thus are several mechanisms by which the intricate homeostasis of energy balance and 
autonomic regulation may be disturbed post-bariatric surgery. We believe that increasing use 
and success of bariatric surgery for obesity provides a compelling need to investigate and 
elicit the mechanism of the disturbance of the OI, be they autonomic, hormonal or a 
combination, so it can be remedied.  
 
Conclusions: 
With rising global obesity rates and increasing use of bariatric surgery, our series, along with 
other reports, indicate that autonomic dysfunction causing OI occurs after bariatric surgery. 
These findings, in particular with the 2008 series, indicate that OI is likely to be 
underreported, even if recognised. A retrospective survey in bariatric centres is needed to 
determine the prevalence of OI after bariatric surgery. This should be in concert with a 
prospective study, ideally including a pre-operative assessment to exclude initial OI, with a 
focus on key factors, associated disorders and if possible mechanisms that may predispose or 
contribute to OI after bariatric intervention. 
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